Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.350
-0.060 (-1.76%)
At close: Mar 28, 2025, 4:00 PM
3.360
+0.010 (0.29%)
After-hours: Mar 28, 2025, 4:56 PM EDT

Eledon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-36.18-116.54-87.97-34.51-22.81
Upgrade
Depreciation & Amortization
0.360.370.370.20.18
Upgrade
Asset Writedown & Restructuring Costs
--48.65--
Upgrade
Loss (Gain) From Sale of Investments
-2.8-1.2---
Upgrade
Stock-Based Compensation
13.126.558.157.93.17
Upgrade
Other Operating Activities
-30.4876.21--2.354.43
Upgrade
Change in Accounts Payable
7.75-2.62.082.14-0.04
Upgrade
Change in Other Net Operating Assets
0.96-2.320.29-2.3-0.14
Upgrade
Operating Cash Flow
-47.27-39.53-28.42-28.91-15.21
Upgrade
Cash Acquisitions
----11.04
Upgrade
Investment in Securities
-70.31-45.29---
Upgrade
Investing Cash Flow
-70.31-45.29--11.04
Upgrade
Issuance of Common Stock
133.5233.02-014.38
Upgrade
Repurchase of Common Stock
-----0.03
Upgrade
Other Financing Activities
----0.45-
Upgrade
Financing Cash Flow
133.5233.02--0.45109.58
Upgrade
Net Cash Flow
15.94-51.8-28.42-29.36105.4
Upgrade
Free Cash Flow
-47.27-39.53-28.42-28.91-15.21
Upgrade
Free Cash Flow Per Share
-0.97-1.61-1.99-1.95-10.48
Upgrade
Levered Free Cash Flow
-21.4-24.47-13.85-15.33-4.01
Upgrade
Unlevered Free Cash Flow
-21.4-24.47-13.85-15.33-4.01
Upgrade
Change in Net Working Capital
-9.234.52-2.480.39-0.94
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q